Methyllycaconitine
CAS: 21019-30-7
Ref. 3D-XM183142
5mg | 453.00 € | ||
10mg | 647.00 € | ||
25mg | 1,160.00 € | ||
50mg | 1,739.00 € | ||
100mg | 2,319.00 € |
Product Information
- (1α,6β,14α,16β)-20-Ethyl-1,6,14,16-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]aconitane-7,8-diol
- Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-, (1alpha,4(S),6beta,14alpha,16beta)-
- Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-[[[2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl]oxy]methyl]-, [1α,4(S),6β,14α,16β]-
- Aconitane-7,8-diol, 20-ethyl-1,6,14,16-tetramethoxy-4-[[[2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoyl]oxy]methyl]-, (1α,6β,14α,16β)-
- Aconitane-7,8-diol, 20-ethyl-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-1,6,14,16-tetramethoxy-, (1-alpha,4(S),6-beta,14-alpha,16-beta)-
- Brn 0076234
- Delartine
- Delsemidine
- Lycaconitine, methyl-
- [(1alpha,6beta,10alpha,13xi,14alpha,16beta,17xi)-20-ethyl-7,8-dihydroxy-1,6,14,16-tetramethoxyaconitan-4-yl]methyl 2-[(3S)-3-methyl-2,5-dioxopyrrolidin-1-yl]benzoate
- See more synonyms
- [(6Beta,14Alpha,16Beta,17Xi)-20-Ethyl-7,8-Dihydroxy-1,6,14,16-Tetramethoxyaconitan-4-Yl]Methyl 2-(3-Methyl-2,5-Dioxopyrrolidin-1-Yl)Benzoate
- [(6Beta,7Beta,13Xi,16Beta)-20-Ethyl-7,8-Dihydroxy-1,6,14,16-Tetramethoxyaconitan-4-Yl]Methyl 2-(3-Methyl-2,5-Dioxopyrrolidin-1-Yl)Benzoate
Methyllycaconitine is a potent inhibitor of kinases, making it a valuable medicinal compound for the treatment of various diseases. It has been shown to induce apoptosis in tumor cells and inhibit the growth of cancer cells in humans. Methyllycaconitine is an analog of lycaconitine, which is a toxic alkaloid found in Chinese herbal medicine. This compound has anticancer properties that make it a promising candidate for the development of new cancer therapies. Its ability to selectively target protein kinases involved in cancer cell growth and survival makes it a valuable tool for cancer research and drug discovery. In addition, methyllycaconitine has shown potential as an inhibitor of urinary bladder contractions, making it useful for treating related disorders.
Chemical properties
Technical inquiry about: 3D-XM183142 Methyllycaconitine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.